Edition:
India

People: Carmat SA (ALCAR.PA)

ALCAR.PA on Paris Stock Exchange

20.45EUR
18 Sep 2020
Change (% chg)

€0.95 (+4.87%)
Prev Close
€19.50
Open
€19.50
Day's High
€20.60
Day's Low
€19.50
Volume
15,374
Avg. Vol
7,712
52-wk High
€22.95
52-wk Low
€10.10

Piat, Stephane 

Mr. Stephane Piat serves as Chief Executive Officer, Director of the Company. Stéphane Piat is an acknowledged specialist in the medical device business, particularly in the field of cardiology. Mr Piat started his career at Becton Dickinson European Headquarters as a Market Researcher in 1995. He was appointed European Platform Leader for Locoregional Anaesthesia five years later. In 2002, he joined Cordis, a Johnson & Johnson company, where he spent five years in several management positions ranging from Business Director France to European Marketing Director for Cardiology. In 2007, he moved to Abbott Vascular as General Manager for mid-size countries, EMEA, and two years later oversaw the integration of Evalve as the company’s General Manager EMEA, heading clinical and commercial development of a new interventional cardiology product, Mitraclip. In 2014, he led Global Market Development of the Abbott Vascular Structural Heart Division in San Francisco as Division Vice President. Mr Piat holds a master’s degree in Management Science from IAE Dijon School of Management, and a post-graduate degree in Quantitative Marketing from ESA business school in Grenoble.

Basic Compensation

Total Annual Compensation, EUR 588,689
Restricted Stock Award, EUR --
Long-Term Incentive Plans, EUR --
All Other, EUR 7,793
Fiscal Year Total, EUR 596,482

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --